Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress in inducing immunogenic cell death of tumor cells
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 99
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 128, pp. 108702-108702
Closed Access | Times Cited: 19
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 11
Label-Free Multiplex Profiling of Exosomal Proteins with a Deep Learning-Driven 3D Surround-Enhancing SERS Platform for Early Cancer Diagnosis
Miao Chen, Haoyang Wang, Yibin Zhang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 17, pp. 6794-6801
Closed Access | Times Cited: 11
Extracellular vesicles-powered immunotherapy: Unleashing the potential for safer and more effective cancer treatment
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 756, pp. 110022-110022
Closed Access | Times Cited: 7
Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death
Rama Rao Malla, Seema Kumari, Swapna Priya Ganji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189154-189154
Closed Access | Times Cited: 7
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products
Lele Zhang, Du-Juan Zhang, Jia-Xin Shi, et al.
Phytomedicine (2024) Vol. 132, pp. 155828-155828
Closed Access | Times Cited: 6
Multifunctional hydrogels based on photothermal therapy: A prospective platform for the postoperative management of melanoma
Wen-Shang Liu, Zhuo Chen, Zhengmao Lu, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 406-428
Closed Access | Times Cited: 5
A Cu‐Based Single‐Atom Nanozyme Platform with Multi‐Enzyme Simulated Activities for Immunotherapy of Prostate Cancer by Regulating Cholesterol Metabolism and Triggering Pyroptosis
Bo Xu, Rui Niu, Ruiping Deng, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 46
Closed Access | Times Cited: 5
Charge Separation‐Engineered Piezoelectric Ultrathin Nanorods Modulate Tumor Stromal Microenvironment and Enhance Cell Immunogenicity for Synergistically Piezo‐Thermal‐Immune Therapy
Qian Wang, Junhui Du, Fujun Yang, et al.
Small (2024)
Closed Access | Times Cited: 5
Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
Lei‐Ming Cao, Nian‐Nian Zhong, Yang Chen, et al.
Cancer Letters (2024) Vol. 598, pp. 217095-217095
Closed Access | Times Cited: 4
Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53
Iulianna C. Taritsa, Eric T. Fossel
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Metal-based immunogenic cell death inducers for cancer immunotherapy
Jun Zou, Meng Rui Chang, Nikita A. Kuznetsov, et al.
Chemical Science (2025)
Open Access
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings
Ling Xu, Xinxin Ma, Yang Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives
Dekang Ren, Shizheng Xiong, Yujie Ren, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1833-1843
Open Access | Times Cited: 3
Promotion of ICD via Nanotechnology
Yang Qin, Haitao Zhang, Yunxian Li, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 8
Heating Tumors with Tumor Cell-Derived Nanoparticles to Enhance Chemoimmunotherapy for Colorectal Cancer
Xinying Li, Ronghui Li, Jun-Zi Cong, et al.
Nanomedicine (2024) Vol. 19, Iss. 7, pp. 561-579
Closed Access | Times Cited: 2
Hydrogels as local depots for on-demand therapeutic delivery: potential therapeutic approaches for tumor metastasis
Abegaz Tizazu Andrgie, Hsieh‐Chih Tsai
Materials Advances (2024) Vol. 5, Iss. 9, pp. 3629-3643
Open Access | Times Cited: 2
Navigating Safety and Toxicity Challenges in Nanomedicine: Strategies, Assessment, and Mitigation
Rajesh Kumar, Sunil Dutt, Abhay Dev Tripathi, et al.
Nanotechnology in the life sciences (2024), pp. 15-37
Closed Access | Times Cited: 2
The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
Deqian Xie, Bowen Jiang, Shijin Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma
Zhenjie He, Xinming Jing, Xiaoyan Dai, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4
Open Access | Times Cited: 1
Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions
Jiaan Lu, Ru He, Yang Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top